← stocks-llm New chat

AGENUS INC (AGEN) — insider trading

Health Care · NASDAQ

AGENUS INC (AGEN) has 14 reported SEC Form 4 insider transactions in our data (latest 2026-07-01).

Recent Form 4 transactions

DateInsiderRoleTypeSharesPriceValueFiling
2026-07-01 Wright Timothy Director Grant / award / vesting (derivative) 2,268 Form 4
2026-07-01 HARRISON THOMAS L Director Grant / award / vesting 8,547 $3.58 $30.6K Form 4
2026-06-26 ARMEN GARO H Director, Officer (See Remarks) Grant / award / vesting 5,364 $3.03 $16.3K Form 4
2026-06-12 ARMEN GARO H Director, Officer (See Remarks) Grant / award / vesting 4,925 $3.30 $16.3K Form 4
2026-05-29 ARMEN GARO H Director, Officer (See Remarks) Grant / award / vesting 4,644 $3.50 $16.3K Form 4
2026-05-15 ARMEN GARO H Director, Officer (See Remarks) Grant / award / vesting 4,540 $3.58 $16.3K Form 4
2026-05-01 ARMEN GARO H Director, Officer (See Remarks) Grant / award / vesting 4,233 $3.84 $16.3K Form 4
2026-04-24 Wright Timothy Director Grant / award / vesting (derivative) 105,000 $0.00 $0 Form 4
2026-04-24 HARRISON THOMAS L Director Grant / award / vesting (derivative) 122,500 $0.00 $0 Form 4
2026-04-24 O'Day Steven J Officer (Chief Medical Officer) Grant / award / vesting (derivative) 95,333 $0.00 $0 Form 4
2026-04-24 O'Day Steven J Officer (Chief Medical Officer) Grant / award / vesting (derivative) 70,000 $0.00 $0 Form 4
2026-04-24 Buell Jennifer Director, Officer (See Remarks) Grant / award / vesting (derivative) 5,000 $0.00 $0 Form 4
2026-04-24 Buell Jennifer Director, Officer (See Remarks) Grant / award / vesting (derivative) 300,000 $0.00 $0 Form 4
2026-04-24 Hirsch Susan B Director Grant / award / vesting (derivative) 105,000 $0.00 $0 Form 4

Ask the chat about AGEN's insider activity →

Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.

Source: SEC EDGAR Form 3/4/5. See the full company profile: AGENUS INC (AGEN).

Last updated 2026-07-01 (most recent filing date).

Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.